Bcl-2 family proteins are essential for platelet survival
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Platelets are relatively short-lived, anucleated cells that are essential for proper hemostasis. The regulation of platelet survival in the circulation remains poorly understood. The process of platelet activation and senescence in vivo is associated with processes similar to those observed during apoptosis in nucleated cells, including loss of mitochondrial membrane potential, caspase activation, phosphatidylserine (PS) externalization, and cell shrinkage. ABT-737, a potent antagonist of Bcl-2, Bcl-X(L), and Bcl-w, induces apoptosis in nucleated cells dependent on these proteins for survival. In vivo, ABT-737 induces a reduction of circulating platelets that is maintained during drug therapy, followed by recovery to normal levels within several days after treatment cessation. Whole body scintography utilizing ([111])Indium-labeled platelets in dogs shows that ABT-737-induced platelet clearance is primarily mediated by the liver. In vitro, ABT-737 treatment leads to activation of key apoptotic processes including cytochrome c release, caspase-3 activation, and PS externalization in isolated platelets. Despite these changes, ABT-737 is ineffective in promoting platelet activation as measured by granule release markers and platelet aggregation. Taken together, these data suggest that ABT-737 induces an apoptosis-like response in platelets that is distinct from platelet activation and results in enhanced clearance in vivo by the reticuloendothelial system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, targeting BCL-XL with conventional inhibitors causes severe thrombocytopenia, limiting their clinical use [5–7].”
From BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers (2022) · cites this paper as [6]
In the citing paper
“a potential clinical limitation of BCL-XLi is the fact that these inhibitors can cause on-target, reversible thrombocytopenia (Zhang et al., 2007).”
From A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution (2017) · cites this paper as Zhang et al., 2007
Citations
Cites
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416 · cited 2×
“ABT-737 is a small molecule antagonist of the prosurvival Bcl-2 family proteins Bcl-XL, Bcl-2, and Bcl-w that induces apoptosis in tumor cells in a mitochondria-dependent fashion.(18) Treatment of ABT-737 in dogs leads to a rapid, dosedependent decrease in circulating platelets that return to baseline within 72-h post…”
BackgroundSelf-citationA receptor for phosphatidylserine-specific clearance of apoptotic cells
Fadok, V. A., Bratton, D. L., Rose, D. M., Pearson, A., Ezekewitz, R. A. B., & Henson, P. M. (2000) · Nature · doi:10.1038/35011084 · Cited by 1,491 · cited 1×
“PS externalization on cells has also been shown to signal the specific engulfment of these unwanted cells by phagocytes leading to clearance from the circulation .(9,15,25) Finally, the fact that the enantiomer negative control does not activate the apoptotic cascade at equivalent concentrations supports the notion th…”
BackgroundThe biogenesis of platelets from megakaryocyte proplatelets
Patel, S. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26891 · Cited by 603 · cited 1×
“The similarities between platelet biogenesis from megakaryocytes and apoptosis include membrane blebbing, membrane condensation, DNA fragmentation, cell shrinkage, and ultimately the formation of apoptotic bodies.(5,6) The consequence of this apoptotic process is that each mature megakaryocyte fragments into thousands…”
BackgroundThe platelet release reaction: granules' constituents, secretion and functions
Rendu, F., & Brohard-Bohn, B. (2001) · Platelets · doi:10.1080/09537100120068170 · Cited by 599 · cited 4×
“Upon platelet activation, a series of granules are released that are essential for the full activation response.(21) To further investigate other direct effects of ABT-737 on platelet dynamics, isolated platelets were treated with ABT-737 and classical markers of granule release were monitored.”
BackgroundMethodInfluentialProgrammed cell death and Bcl-2 protection in the absence of a nucleus.
Jacobson, M. D., Burne, J. F., & Raff, M. C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06459.x · Cited by 552 · cited 1×
“Previous studies have shown that apoptotic agents promote morphological changes in anucleated cytoplast that resemble characteristics of programmed cell death.(23,24) In platelets, the morphological changes of apoptosis closely resemble those of activation, including PS externalization, microparticle release (i.”
BackgroundMartin, S. J., Finucane, D. M., Amarante-Mendes, G. P., O'Brien, G. A., & Green, D. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28753 · Cited by 372 · cited 1×
“Previous studies have shown that apoptotic agents promote morphological changes in anucleated cytoplast that resemble characteristics of programmed cell death.(23,24) In platelets, the morphological changes of apoptosis closely resemble those of activation, including PS externalization, microparticle release (i.”
BackgroundWolf, B. B., Goldstein, J. C., Stennicke, H. R., Beere, H., Amarante-Mendes, G. P., Salvesen, G. S., & Green, D. R. (1999) · Blood · doi:10.1182/blood.v94.5.1683 · Cited by 323
The role of the Bcl-2 protein family in cancer
Coultas, L., & Strasser, A. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00129-3 · Cited by 242 · cited 1×
“The process of apoptosis can be viewed as a cascade of events initiating from the accumulation of a death signal(s), release of apoptotic factors from the mitochondria, activation of initiator/effector caspases, ultimately leading to cell death.(16) Our studies demonstrate that ABT-737 initiates the apoptotic cascade…”
BackgroundA Simple Nonradioisotope Technic for the Determination of Platelet Life-Span
Stuart, M. J., Murphy, S., & Oski, F. A. (1975) · New England Journal of Medicine · doi:10.1056/nejm197506192922502 · Cited by 242 · cited 1×
“released into the circulation, platelets rapidly age with a halflife of 4–5 days.(7,8) As platelets age, they lose their ability to function and are subsequently removed from circulation.”
BackgroundRole of platelets in thrombosis and hemostasis
Packham, M. A. (1994) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y94-043 · Cited by 215 · cited 2×
“Subsequent platelet activation, granule release, and aggregation are essential for the formation of a hemostatic plug that limits blood loss and stimulates repair.(2) There are several morphological changes associated with platelet activation that are reminiscent of nucleated cell apoptosis.”
BackgroundThe mechanism of apoptosis in human platelets during storage
Li, J., Xia, Y., Bertino, A. M., Coburn, J. P., & Kuter, D. J. (2000) · Transfusion · doi:10.1046/j.1537-2995.2000.40111320.x · Cited by 181 · cited 2×
“, Bax, Bak, Bcl-XL, and Bcl-2) are also expressed in platelets.(11,12,14,15) The Bcl-2 family of proteins is the key regulators of mitochondria-dependent”
BackgroundConstitutive Death of Platelets Leading to Scavenger Receptor-mediated Phagocytosis
Brown, S. B., Clarke, M. C. H., Magowan, L., Sanderson, H., & Savill, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5987 · Cited by 168 · cited 2×
“, Bax, Bak, Bcl-XL, and Bcl-2) are also expressed in platelets.(11,12,14,15) The Bcl-2 family of proteins is the key regulators of mitochondria-dependent”
BackgroundRole of Caspase in a Subset of Human Platelet Activation Responses
Shcherbina, A., & Remold-O’Donnell, E. (1999) · Blood · doi:10.1182/blood.v93.12.4222 · Cited by 162
Clarke, M. C. H., Savill, J., Jones, D. B., Noble, B. S., & Brown, S. B. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200210111 · Cited by 150
Vanags, D. M., Orrenius, S., & Aguilar‐Santelises, M. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4813284.x · Cited by 129 · cited 1×
“, Bax, Bak, Bcl-XL, and Bcl-2) are also expressed in platelets.(11,12,14,15) The Bcl-2 family of proteins is the key regulators of mitochondria-dependent”
BackgroundApoptotic markers are increased in platelets stored at 37°C
Bertino, A. M., Qi, X. Q., Li, J., Xia, Y., & Kuter, D. J. (2003) · Transfusion · doi:10.1046/j.1537-2995.2003.t01-4-00431.x · Cited by 125
BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis: Figure 1.Preprint
Gélinas, C., & White, E. (2005) · Genes & Development · doi:10.1101/gad.1326205 · Cited by 120
Soto, M., Palomo, I. F., Ocqueteau, M. E., Coetzee, L. M., Astudillo, S., Aranda, E., Mezzano, D., & Pereira, J. I. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613103 · Cited by 83 · cited 2×
“However, it has been associated with a decrease in the mitochondrial membrane potential (Dcm) and loss of membrane asymmetry, analogous to events observed in apoptosis.(9,10)”
BackgroundResultPlatelet-Collagen Responses: Molecular Basis and Therapeutic Promise
Kahn, M. L. (2004) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2004-833477 · Cited by 71 · cited 1×
“activator that rapidly induces aggregation, rendering platelets undetectable by the size exclusion techniques used here.(19) As expected, collagen induced platelet aggregation that manifested as a reduction in measured platelet counts at all time points.”
MethodAntiplatelet agents and perioperative bleeding
Lecompte, T., & Hardy, J. (2006) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03022257 · Cited by 64
Sanz, C., Benet, I., Richard, C., Badia, B., Andreu, E. J., Prósper, F., & Fernández-Luna, J. L. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00635-x · Cited by 57 · cited 1×
“The lower expression levels of Bcl-2 are consistent with previous observations indicating the presence of negligible amounts of Bcl-2 in mature platelets.(26) In comparison, the levels of Bcl-XL in platelets are significantly greater than Bcl-2, suggesting that Bcl-XL may play a larger role in platelet survival.”
ResultManoharan, A., Gemmell, R., Brighton, T., Dunkley, S. M., Lopez, K., & Kyle, P. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01399.x · Cited by 50 · cited 1×
“The ability of compounds to induce aggregation was determined by measuring the impedance (Ohms) of the whole blood which is directly proportional to the aggregatory response.(20) As expected, collagen alone elicited a robust response at all the time points illustrating the stability of the platelets over the course of…”
MethodJudge, H. M., Buckland, R. J., Holgate, C. E., & Storey, R. F. (2005) · Platelets · doi:10.1080/09537100500163226 · Cited by 42
Troy, G. C. (1988) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/s0195-5616(88)50003-7 · Cited by 41
Platelet Aging In Vivo Is Associated with Loss of Membrane Phospholipid Asymmetry
Palomo, I. F., Ocqueteau, M. E., Soto, M., Aranda, E., Mezzano, D., & Pereira, J. I. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614383 · Cited by 34 · cited 3×
“However, it has been associated with a decrease in the mitochondrial membrane potential (Dcm) and loss of membrane asymmetry, analogous to events observed in apoptosis.(9,10)”
BackgroundResultRole of Apoptotic Processes in Platelet Biogenesis
Kaluzhny, Y., & Ravid, K. (2003) · Acta Haematologica · doi:10.1159/000074487 · Cited by 32 · cited 2×
“The consequence of this apoptotic process is that each mature megakaryocyte fragments into thousands of platelets.(5) Once”
BackgroundPlatelet Aggregation Inhibition with Glycoprotein IIb–IIIa Inhibitors
Proimos, G. (2001) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1011216414539 · Cited by 31
Kinetics and distribution of platelets in man
Tsan, M. (1984) · American Journal of Hematology · doi:10.1002/ajh.2830170114 · Cited by 23 · cited 1×
“released into the circulation, platelets rapidly age with a halflife of 4–5 days.(7,8) As platelets age, they lose their ability to function and are subsequently removed from circulation.”
BackgroundKawabata, K., Nakai, S., Miwa, M., Sugiura, T., Otsuka, Y., Shinzato, T., Hiki, Y., Tomimatsu, I., Ushida, Y., Hosono, F., et al. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000054726 · Cited by 17 · cited 1×
“GPIIb/IIIa is a platelet surface protein that undergoes a conformational change upon platelet activation and mediates interactions between the platelets and other coagulation factors such as fibrinogen.(22) The active conformation of GPIIb/IIIa is readily detectable by PAC-1, an antibody that specifically recognizes o…”
BackgroundFryer, R. M., Preusser, L. C., Calzadilla, S. V., Hu, Y., Xu, H., Marsh, K. C., Cox, B. F., Lin, C. T., Gopalakrishnan, M., & Reinhart, G. A. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200408000-00001 · Cited by 14
Self-citationFryer, R. M., Rakestraw, P. A., Preusser, L. C., Brune, M. E., Carroll, W. A., Buckner, S. A., Shieh, C., King, L. L., Marsh, K. C., Gopalakrishnan, M., et al. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000171755.28317.85 · Cited by 6 · cited 1×
“Subsequently, animals were instrumented to record numerous cardiovascular parameters as previously described.(30,31) Following completion of the surgical protocol, animals were allowed to recover for 1 h.”
MethodSelf-citation
Cited by
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
Self-citationABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
“We recently reported that ABT-737 induces a rapid and reversible thrombocytopenia in animals resulting from inhibition of Bcl-2 family proteins and induction of apoptosis in circulating platelets without bone marrow toxicity (29).”
BackgroundSelf-citationFisetin is a senotherapeutic that extends health and lifespan
Yousefzadeh, M. J., Zhu, Y., McGowan, S. J., Angelini, L., Fuhrmann-Stroissnigg, H., Xu, M., Ling, Y. Y., Melos, K. I., Pirtskhalava, T., Inman, C. L., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.015 · Cited by 1,032
“Navitoclax, and could be repurposed as senolytics, but cause considerable toxicity including neutropenia and platelet deficiency [40,41].”
BackgroundProgrammed Anuclear Cell Death Delimits Platelet Life Span
Mason, K. D., Carpinelli, M. R., Fletcher, J. I., Collinge, J. E., Hilton, A. A., Ellis, S., Kelly, P. N., Ekert, P. G., Metcalf, D., Roberts, A. W., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.037 · Cited by 1,031
From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
Ashkenazi, A., Fairbrother, W. J., Leverson, J. D., & Souers, A. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.253 · Cited by 903
Metadata
- Authors
- Zhang, H., Nimmer, P. M., Tahir, S. K., Chen, J., Fryer, R. M., Hahn, K. R., Iciek, L. A., Morgan, S. J., Nasarre, M. C., Nelson, R., Preusser, L. C., Reinhart, G. A., Smith, M. L., Rosenberg, S. H., Elmore, S. W., & Tse, C.
- Affiliations
- Abbott (United States) (US)
- Corresponding author
- Elmore, S W
- Tse, C
- Venue
- Cell Death & Differentiation
- Published
- 2007-01-05
- Volume
- 14
- Issue
- 5
- Pages
- 943-951
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W1976197588
- Cited by
- 427
- References
- 32
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 17 · 2023: 20 · 2022: 28 · 2021: 38 · 2020: 31 · 2019: 15 · 2018: 24 · 2017: 27 · 2016: 27 · 2015: 23 · 2014: 27 · 2013: 26 · 2012: 21
- FWCI
- 11.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- platelet survival, Bcl-2 family proteins, ABT-737, platelet clearance, caspase-3 activation, cytochrome c release, phosphatidylserine exposure, mitochondrial membrane potential, reticuloendothelial system, hepatic clearance, platelet activation, hemostasis
- MeSH terms
- Animals, Biphenyl Compounds, Blood Platelets, Cell Separation, Cell Survival, Cytoplasmic Granules, Dogs, Dose-Response Relationship, Drug, Exocytosis, Flow Cytometry, Humans, Liver, Male, Nitrophenols, Phosphatidylserines, Piperazines, Platelet Aggregation, Platelet Count, Sulfonamides, Apoptosis, Proto-Oncogene Proteins c-bcl-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.